Event Information

Clinical Excellence in Action: Multidisciplinary, Regional Perspectives on BRCA-Mutated mCRPC Case Management

Type
Webinar

EVENT DETAILS

Display Date
Monday December 9th, 2024
Display Date Line 2
20:00 ET
Speaker
C. Y. Michael Chang, Kim Chi & Michael Ong

ACCREDITATION

Accreditation
Section 1 Group Learning Credits
Event Description

Speakers: Michael Chang, Kim Chi & Michael Ong

Objectives
By participating in this learning program, healthcare providers can expect to gain an understanding of:

  • Understand the latest testing and treatment considerations for advanced prostate cancer patients, including those with BRCA mutations
  • Navigate complex BRCA-mutated mCRPC cases across diverse healthcare settings
  • Leverage multi-disciplinary insights on effective adverse event management
  • Formulate strategies to optimize multidisciplinary patient care plans
REGISTER
Footer

ACCREDITATION

This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by CUA. You may claim a maximum of 1 hour of credit.

 ________________________
Sponsor:
Sponsor

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy